“Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab)”, Reumatismo, vol. 61, no. 4, pp. 306–308, Sep. 2009, doi: 10.4081/reumatismo.2009.306.